Neonatal Optical Coherence Tomography Angiography to Assess the Effects of Postnatal Exposures on Retinal Development and Predict Neurodevelopmental Outcomes
Neonatal Optical Coherence Tomography Angiography to Assess the Effects of Postnatal Exposures on Retinal Development and Predict Neurodevelopmental Outcomes
批准号:
10588086
负责人:
Alison Chu
金额:
$40.68万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-07-01 至 2027-06-30
关键词:
3 year old5 year oldAdultAffectAgeAlzheimer&aposs DiseaseAnesthesia proceduresAngiographyBiological MarkersBirthBirth WeightBlood VesselsBrainCause of DeathChildChoroidCognitiveCounselingCystoid Macular EdemaDataDevelopmentDevicesDiabetic RetinopathyDisease ProgressionEarly InterventionEpidemicEvaluationExposure toEyeEye DevelopmentFutureGanglion Cell LayerGermanyGestational AgeGoalsHeadImageImpairmentInfantInpatientsIntensive CareLanguageLasersLifeLungMagnetic Resonance ImagingMeasurementMeasuresMicroscopicMotorNeonatalNeurodevelopmental ImpairmentNeurologicNewborn InfantOperative Surgical ProceduresOptical Coherence TomographyOutcomeOxygenPatient CarePatient-Focused OutcomesPhasePopulationPredictive ValuePremature BirthPremature InfantReportingRetinaRetinopathy of PrematurityRiskSchool-Age PopulationSecondary toSeveritiesTestingThickThinnessTreatment FactorVascular Endothelial Growth FactorsVascular blood supplyVisionVisualVisual AcuityVisual impairmentVulnerable Populationsarmblood vessel developmentcohortcomorbiditycritical periodhigh riskhigh risk infantimprovedindexingindividualized medicineintravitreal injectionmaculaneonatal periodneonatenervous system disorderneurodevelopmentneuroimagingpostnatalpostnatal periodprematurepreterm newbornresponseretina blood vessel structureretinal nerve fiber layersupplemental oxygentomographytreatment effecttreatment riskultrasound
中文摘要
项目总结/文摘
英文摘要
PROJECT SUMMARY/ABSTRACT
Worldwide, more than 1 in 10 babies are born premature. Prematurity is not only the leading cause of death in
children under 5 years of age, but also has serious long-term consequences for those preterm infants who
survive. As such, there is a growing population of infants at risk for retinopathy of prematurity (ROP), visual
impairment and neurodevelopmental impairment. Understanding how the eye is altered due to preterm birth,
while accounting for postnatal factors such as oxygen use and anti-vascular endothelial growth factor (anti-
VEGF) treatment, is key to determining those infants at highest risk for visual and neurodevelopmental
impairment. Historically, this vulnerable population has been difficult to study, as invasive testing is both difficult
to perform as well as potentially harmful. Our study will utilize non-invasive eye imaging, using ocular coherence
tomography and angiography (OCT/OCTA), in preterm and term infants requiring intensive care. These images
will be analyzed using established measures, to identify how eye development differs in newborn infants exposed
to various systemic and local treatments such as oxygen and anti-VEGF intravitreal injections. Moreover, we will
identify retinal biomarkers from OCT/OCTA imaging that predict a number of key visual and development
outcomes, including treatment-requiring ROP shortly after birth and visual and neurodevelopmental impairment
at 2-3 years of age. Results from these studies will broaden and deepen our understanding of retinal blood vessel
development in preterm infants, the eye’s response to oxygen and anti-VEGF. In addition, developing non-
invasive retinal biomarkers as predictors for visual and neurodevelopmental impairment will augment
identification of at-risk infants early in the postnatal period will help to initiate individualized therapies during a
period of critical neurodevelopment which will optimize their long-term outcomes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting epithelial membrane protein 2 (EMP2) in retinopathy of prematurity
-
批准号:10183025
-
项目类别:
-
资助金额:$40.56万
-
财政年份:2021
-
负责人:Alison Chu
-
依托单位:
Targeting epithelial membrane protein 2 (EMP2) in retinopathy of prematurity
-
批准号:10624426
-
项目类别:
-
资助金额:$39.16万
-
财政年份:2021
-
负责人:Alison Chu
-
依托单位:
Targeting epithelial membrane protein 2 (EMP2) in retinopathy of prematurity
-
批准号:10404080
-
项目类别:
-
资助金额:$37.99万
-
财政年份:2021
-
负责人:Alison Chu
-
依托单位:
海外基金